These results indicated that low-concentration PGD2 increased cell proliferation mainly through binding to CRTH2, while CRTH2 did not play a major role in the anti-proliferation effects of high-concentration PGD2 in DLBCL cells. The gene discussed is PTGDR2; the disease is diffuse large B-cell lymphoma.